Chiron ends clinical trial of HIV treatment
BY Advocate.com Editors
October 25 2002 12:00 AM ET
Chiron Corp. announced Wednesday that it is ending the development of three compounds, including a recombinant form of interleukin-2 being studied in a Phase III trial for the treatment of patients with HIV. The company had been expected to complete the clinical trial, including patient follow-up, in 2007. Chiron is now reviewing data for a possible regulatory submission for approval of IL-2 only in a small subset of HIV-positive patients who do not receive any response to other anti-HIV medications. The company also stopped development of compounds intended to treat cystic fibrosis and hepatitis B.
- Meet the Same-Sex Couple Who Made Dodger Stadium Swoon
- WATCH: You’ll Cry When You See What Happened During That Gay-Straight Prom Date
- WATCH: Dodger Stadium Reacts to Same-Sex Couple on Kiss Cam
- WATCH: The 8 Most Hateful Things Texas Lawmakers Said Monday
- RuPaul's Drag Race's Miss Fame: I've Yet to Leave My 'Beauty Mark'
- WATCH: Texas B&B Boots Gay Couple, Gets Banned From Airbnb